Hakan Kardes - Apr 20, 2023 Form 3 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role: Chief Technology Officer
Signature: /s/ Richard A. Cross, as Attorney-in-Fact, for Hakan Kardes
Stock symbol: ALHC
Transactions as of: Apr 20, 2023
Transactions value $: $0
Form type: 3
Date filed: 5/1/2023, 08:00 PM
Next filing: Mar 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ALHC	Common Stock						318K	Apr 20, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALHC	Options (Right to Buy)							Apr 20, 2023	Common Stock	69.3K	$18.00	Direct	F3
holding	ALHC	Options (Right to Buy)							Apr 20, 2023	Common Stock	36.5K	$9.06	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (i) 113,657 shares of Common Stock of Alignment Healthcare, Inc. (the "Company"); (ii) 20,566 shares of unvested restricted stock, all of which vest on July 15, 2023; (iii) 20,376 shares of unvested restricted stock, 50% of which vest on each of August 1, 2023 and August 1, 2024; (iv) 10,283 shares of unvested restricted stock, all of which vest on November 19, 2023; (v) 5,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company ("RSUs"), granted on March 25, 2021, 25% of which vested or will vest on each of the first four anniversaries of the grant date; (Cont.)
F2	(Cont. from footnote 1) (vi) 66,000 RSUs granted on April 9, 2021, 25% of which vested or will vest on each of the first four anniversaries of the grant date; (vii) 49,669 RSUs granted on March 8, 2022, 25% of which vested or will vest on each of the first four anniversaries of the grant date; and (viii) 44,482 RSUs granted on September 12, 2022, 50% of which will vest on or about each of the third and fourth anniversaries of the grant date. An aggregate of 12,626 shares have been sold upon vesting of RSUs in non-discretionary sale-to-cover transactions. In each case, vesting is subject to the reporting person's continued service to the Company as of the applicable vesting date.
F3	Options vested or will vest 25% on each of the first four anniversaries of the March 25, 2021 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
F4	Options vested or will vest 25% on each of the first four anniversaries of the March 8, 2022 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.